当前位置:首页 - 行情中心 - 沃森生物(300142) - 财务分析

沃森生物

(300142)

  

流通市值:224.74亿  总市值:230.33亿
流通股本:15.68亿   总股本:16.07亿

沃森生物(300142)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年第一季度实现净利润0.38亿元,每股收益0.01元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年第一季度最新股东权益1143367.22万元,未分配利润291696.40万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年第一季度最新总资产1538688.19万元,负债395320.96万元。

利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入599,753,563.654,113,772,327.173,158,044,365.352,167,671,315.8
营业总成本462,149,769.993,152,213,298.292,320,868,365.211,526,144,421.03
营业利润59,649,154.49613,966,148.25779,311,646.09632,055,471.94
利润总额57,253,230.61598,976,487.3774,221,056.21628,023,759.87
净利润38,312,226.91511,325,097.99697,229,401.89562,549,133.38
其他综合收益----
综合收益总额38,312,226.91511,325,097.99697,229,401.89562,549,133.38
资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计8,496,107,457.088,733,170,395.368,790,013,337.188,996,269,388.77
非流动资产合计6,890,774,419.56,855,698,878.046,801,140,608.856,654,064,647.2
资产总计15,386,881,876.5815,588,869,273.415,591,153,946.0315,650,334,035.97
流动负债合计2,977,682,568.573,203,906,735.463,032,084,782.013,263,990,487.55
非流动负债合计975,527,059.13989,602,515.97957,804,838.15919,759,491.06
负债合计3,953,209,627.74,193,509,251.433,989,889,620.164,183,749,978.61
归属于母公司股东权益合计9,363,403,743.199,349,276,209.079,551,615,624.599,453,478,984.06
股东权益合计11,433,672,248.8811,395,360,021.9711,601,264,325.8711,466,584,057.36
负债和股东权益合计15,386,881,876.5815,588,869,273.415,591,153,946.0315,650,334,035.97
现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计631,845,824.415,084,958,951.523,740,025,436.082,260,200,652.22
经营活动现金流出小计707,439,256.183,951,190,153.792,879,089,071.861,874,533,781.8
经营活动产生的现金流量净额-75,593,431.771,133,768,797.73860,936,364.22385,666,870.42
投资活动现金流入小计-147,521,689.62147,181,164.62147,017,506.12
投资活动现金流出小计162,349,214.98955,515,596.79721,409,282.85464,262,407.4
投资活动产生的现金流量净额-162,349,214.98-807,993,907.17-574,228,118.23-317,244,901.28
筹资活动现金流入小计183,938.75632,008,709.23353,468,312.12258,073,814.48
筹资活动现金流出小计14,408,241.68395,364,767.13359,724,625.62258,257,615.65
筹资活动产生的现金流量净额-14,224,302.93236,643,942.1-6,256,313.5-183,801.17
汇率变动对现金及现金等价物的影响93,307.832,274,863.672,602,714.181,050,183.78
现金及现金等价物净增加额-252,073,641.85564,693,696.33283,054,646.6769,288,351.75
期末现金及现金等价物余额4,102,789,069.734,354,862,711.584,073,223,661.923,859,457,367
TOP↑